Export

Salbutamol
Essential medicine status
General description

INN
Salbutamol
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Asthma
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antiasthmatic and medicines for chronic obstructive pulmonary disease
  • Parenteral > General injections > IV: 50 µg per mL in 5 mL ampoule (as sulfate)
  • Respiratory > Inhalation > aerosol: 100 µg per dose (as sulfate); 100 µg per dose (as sulfate) metered-dose inhaler
  • Respiratory > Inhalation > solution: 5 mg per mL (as sulfate) for use in nebulizers